Patients with nonalcoholic fatty liver disease (NAFLD), particularly in the presence of nonalcoholic steatohepatitis or fibrosis, are at high cardiac and cerebrovascular risk.1.
Lombardi, R., Petta, S., Pisano, G., Dongiovanni, P., Rinaldi, L., Adinolfi, L.E., et al. (2020). FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY [10.1016/j.cgh.2018.11.011].
FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage
Petta, Salvatore;Boemi, Roberta;Spatola, Federica;Craxì, Antonio;
2020-01-01
Abstract
Patients with nonalcoholic fatty liver disease (NAFLD), particularly in the presence of nonalcoholic steatohepatitis or fibrosis, are at high cardiac and cerebrovascular risk.1.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S1542356518312540-main.pdf
accesso aperto
Tipologia:
Pre-print
Dimensione
147.46 kB
Formato
Adobe PDF
|
147.46 kB | Adobe PDF | Visualizza/Apri |
|
1-s2.0-S1542356518312540-main.pdf
Solo gestori archvio
Tipologia:
Versione Editoriale
Dimensione
139.61 kB
Formato
Adobe PDF
|
139.61 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
